We are live on ! Find out more
CYTO

Altamira Therapeutics Ltd
CYTO

Delisted

CYTO was delisted on the 19th of December, 2024.

Back to rankings

7 hedge funds and large institutions have $37.9M invested in Altamira Therapeutics Ltd in 2015 Q1 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

39% more capital invested

Capital invested by funds: $27.3M → $37.9M (+$10.6M)

17% more funds holding

Funds holding: 6 → 7 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
+$1.21M
2
SFM
Sphera Funds Management
Israel
+$806K

Top Sellers

Rank Fund Capital Flow
1
CCP
Clough Capital Partners
Massachusetts
-$1.67M
2
Deutsche Bank
Deutsche Bank
Germany
-$43K
Name Holding Trade Value Shares
Change 		Change in
Stake
BAMS
1
Bellevue Asset Management (Switzerland)
Switzerland
$11.6M +$10.9M +27 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$8.92M – – –
CPCM
3
Clifton Park Capital Management
Delaware
$8.88M – – –
RCM
4
RA Capital Management
Massachusetts
$5.03M – – –
SAM
5
Sectoral Asset Management
Quebec, Canada
$1.5M +$1.21M +3 New
SFM
6
Sphera Funds Management
Israel
$997K +$806K +2 New
Alyeska Investment Group
7
Alyeska Investment Group
Illinois
$614K – – –
Goldman Sachs
8
Goldman Sachs
New York
$92K – – –
SIM
9
Spark Investment Management
New York
$85K – – –
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$64K – – –
WA
11
Wasatch Advisors
Utah
$57K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$14K – – –
Bank of America
13
Bank of America
North Carolina
$4K – – –
UBS Group
14
UBS Group
Switzerland
$4K – – –
Morgan Stanley
15
Morgan Stanley
New York
$1K – – –
CCP
16
Clough Capital Partners
Massachusetts
– -$1.67M -5 Closed
Deutsche Bank
17
Deutsche Bank
Germany
– -$43K – –

CYTO Hedge Fund Activity: Q1 2015 in Review

7 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Altamira Therapeutics Ltd (CYTO) for Q1 2015, worth a combined $37.9M — up 39% from $27.3M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new CYTO positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $1.21M. The largest seller was Clough Capital Partners, exiting entirely with an estimated $1.67M sold.

  • 7 institutional investors held Altamira Therapeutics Ltd (CYTO) as of Q1 2015, up from 6 in Q4 2014.
  • Funds reported $37.9M of Altamira Therapeutics Ltd stock for Q1 2015, up 39% quarter-over-quarter.
  • 3 funds opened new Altamira Therapeutics Ltd positions in Q1 2015 and 1 closed out, a net change of +2 holders.
  • The largest Altamira Therapeutics Ltd buyer in Q1 2015 was Sectoral Asset Management, an estimated $1.21M added.
  • The largest Altamira Therapeutics Ltd seller in Q1 2015 was Clough Capital Partners, an estimated $1.67M sold.

Based on aggregated 13F filings for Q1 2015.